AURISCO PHARMACEUTICAL CO.,LTD revenue for the last year amounted to 1.26 B CNY, the most of which — 300.41 M CNY — came from its highest performing source at the moment, Cardiovascular, the year earlier bringing 236.66 M CNY. The greatest contribution to the revenue figure was made by Overseas — last year it brought AURISCO PHARMACEUTICAL CO.,LTD 1.09 B CNY, and the year before that — 927.99 M CNY.